EcoDrugPlus

Phosphodiesterase 4d

Ensembl ID : ENSSARG00000004730
Gene Symbol: PDE4D
1 External references
244 Possible Orthologues:

Phosphodiesterase 5a

Ensembl ID : ENSSARG00000013600
Gene Symbol: PDE5A
1 External references
220 Possible Orthologues:

Phosphodiesterase 7b

Ensembl ID : ENSSARG00000006768
Gene Symbol: PDE7B
3 External references
189 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 1

Ensembl ID : ENSSARG00000000928
Gene Symbol: PIK3R1
1 External references
203 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 3

Ensembl ID : ENSSARG00000002434
Gene Symbol: PIK3R3
1 External references
274 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 5

Ensembl ID : ENSSARG00000006854
Gene Symbol: PIK3R5
3 External references
255 Possible Orthologues:

Phosphoribosylglycinamide Formyltransferase, Phosphoribosylglycinamide Synthetase, Phosphoribosylaminoimidazole Synthetase

Ensembl ID : ENSSARG00000012341
Gene Symbol: GART
1 External references
215 Possible Orthologues:

Platelet Activating Factor Receptor

Ensembl ID : ENSSARG00000005749
Gene Symbol: PTAFR
3 External references
224 Possible Orthologues:

Platelet Derived Growth Factor Receptor Alpha

Ensembl ID : ENSSARG00000001757
Gene Symbol: PDGFRA
1 External references
204 Possible Orthologues:

Platelet Derived Growth Factor Subunit B

Ensembl ID : ENSSARG00000010056
Gene Symbol: PDGFB
1 External references
261 Possible Orthologues:

Polo Like Kinase 1

Ensembl ID : ENSSARG00000010172
Gene Symbol: PLK1
1 External references
183 Possible Orthologues:

Poly(Adp-Ribose) Polymerase 2

Ensembl ID : ENSSARG00000014464
Gene Symbol: PARP2
1 External references
185 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).